Disclaimer: There will be no
references or reference to acronyms in the Cardiology Topics web page.
The information will represent the topic as understood by the
writer.
INFECTIVE
ENDOCARDITIS PROPHYLAXIS.
Dr
Murray
F. Matangi MB ChB, FRACP, FRCPC, FACP, FACC
Cardiologist
Kingston Heart Clinic
Major
changes in the updated recommendations include the
following:
(1)
Emphasis that most cases of endocarditis are not attributable to
an invasive procedure.
(2)
Cardiac conditions are stratified into high-, moderate-,
and negligible-risk categories based on potential outcome if
endocarditis develops.
(3)
Procedures that may cause bacteremia and for which
prophylaxis is recommended are more clearly specified.
(4)
An algorithm was developed to more clearly define when
prophylaxis is recommended for patients with mitral valve prolapse.
(5)
For oral or dental procedures the initial amoxicillin dose
is reduced to 2 g, a follow-up antibiotic dose is no longer
recommended, erythromycin is no longer recommended for
penicillin-allergic individuals, but clindamycin and other
alternatives are offered.
(6)
For gastrointestinal or genitourinary procedures, the
prophylactic regimens have been simplified. These changes were
instituted to more clearly define when prophylaxis is or is not
recommended, improve practitioner and patient compliance, reduce
cost and potential gastrointestinal adverse effects, and approach
more uniform worldwide recommendations.
The
Spectrum of Patients at risk for Endocarditis.
Traditional
Risk:
1.
Most congenital cardiac malformations.
2.
Rheumatic and other aquired valvular dysfunction.
3.
Hypertrophic cardiomyopathy.
4.
Mitral valve prolapse with valvular regurgitation.
Highest risk:
5.
Previous endocarditis.
6.
Prosthetic cardiac valves, mechanical and bioprosthetic.
7.
Systemic to pulmonary surgical shunts for cyanotic
congenital HD.
8.
Complex cyanotic congenital heart disease.
Controversial risk:
9.
The many other patients with mitral valve prolapse. **
10.
Permanent
pacemaker and ICD implants within 6 months of implant.
11.
Patients with
other indwelling intra-vascular catheters.
12.
Mitral
regurgitation due to papillary muscle dysfunction.
13.
Ventriculo-jugular
shunts for hydrocephalus.
14.
Synthetic
vascular grafts within the first 6 months of surgery.
15.
Renal dialysis
patients with AV fistulas.
16.
Patients with
prosthetic joints, hip, knee or shoulder.
**
patients with MVP who have thickening or redundancy of the mitral
valve are probably at increased risk and should have prophylaxis,
particularly men >45 years of age.
LOW
or NO RISK of Infective Endocarditis.
1.
Isolated secundum atrial septal defect.
2.
Beyond 6 months after repair of ASD, VSD or Patent Ductus.
3.
Cardiac transplant patients.
4.
CABG patients.
5.
Physiologic or functional murmurs.
6.
Previous rheumatic fever without cardiac involvement.
7.
Kawasaki disease without valvular involvment.
8.
Parenteral drug abuse without valvular involvement.
Procedures
which entail risk for Infective Endocarditis.
1.
Dental procedures known to produce gingival or mucosal
bleeding including cleaning.
2.
Tonsillectomy and adenoidectomy.
3.
Surgical operations involving intestinal or respiratory
mucosa.
4.
Bronchoscopy with a rigid bronchoscope.
5.
Sclerotherapy for esophageal varices.
6.
Esophageal stricture dilatation.
7.
ERCP.
8.
Cholecystectomy.
9.
Cystoscopy.
10.
Urethral
dilatation.
11.
Urinary catheterization in the presence of urinary
infection.
12.
Urinary tract surgery in the presence of urinary infection.
13.
Prostatic surgery.
14.
Incision and drainage of infected tissue.
15.
Vaginal delivery in the presence of infection.
16.
Endotonia.
17.
Endoaortic instrumentation or surgery.
Procedures
which entail uncertain risk for Infective Endocarditis.
1.
Alveolar ridge incision in denture patients without
pre-existent ulceration.
2.
Various crown and bridge procedures.
3.
Nasal septoplasty.
4.
Ear piercing.
5.
Acupuncture.
6.
Dermatologic procedures.
7.
Inguinal herniorraphy.
8.
Lithotripsy.
9.
Trans-rectal prostatic biopsy.
10.
Transesophageal echocardiography.


END.
|